During the past decade, Department of Clinical Pharmacology, Grünenthal GmbH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Clinical Pharmacology, Grünenthal GmbH" are "Pharmacokinetic" (1 trials) and "Pharmacokinetics" (1 trials). Many other conditions were trialed in "Department of Clinical Pharmacology, Grünenthal GmbH" in a lesser frequency.

Most popular intervention types in "Department of Clinical Pharmacology, Grünenthal GmbH" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "4 ml CG5503" (1 trials), "5 g charcoal powder" (1 trials), "Tapentadol Prolonged-release Reference Product" (1 trials), "Tapentadol Test Product 1" (1 trials) and "Tapentadol Test Product 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Clinical Pharmacology, Grünenthal GmbH" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Department of Clinical Pharmacology, Grünenthal GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Clinical Pharmacology, Grünenthal GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Clinical Pharmacology, Grünenthal GmbH, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".